Free Trial

P3 Health Partners (PIII) Stock Forecast & Price Target

0.00 (0.00%)
(As of 07/19/2024 ET)

P3 Health Partners - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 3 Wall Street analysts who have issued ratings for P3 Health Partners in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for PIII.

Consensus Price Target

759.88% Upside
High Forecast$5.00
Average Forecast$4.75
Low Forecast$4.50

According to the 3 analysts' twelve-month price targets for P3 Health Partners, the average price target is $4.75. The highest price target for PIII is $5.00, while the lowest price target for PIII is $4.50. The average price target represents a forecasted upside of 759.88% from the current price of $0.55.

TypeCurrent Forecast
7/22/23 to 7/21/24
1 Month Ago
6/22/23 to 6/21/24
3 Months Ago
4/23/23 to 4/22/24
1 Year Ago
7/22/22 to 7/22/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
0 Buy rating(s)
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$4.75$4.75$4.75N/A
Forecasted Upside759.88% Upside264.64% Upside264.64% UpsideN/A
Get P3 Health Partners Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter.

PIII Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PIII Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

P3 Health Partners Stock vs. The Competition

TypeP3 Health PartnersMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside759.88% Upside3,241.48% Upside10.07% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/1/2024William Blair
2 of 5 stars
 Reiterated RatingOutperform
4/1/2024BTIG Research
2 of 5 stars
 DowngradeBuy ➝ Neutral
3/14/2024Lake Street Capital
3 of 5 stars
 Lower TargetBuy ➝ Buy$9.00 ➝ $4.50+366.80%
6/30/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:00 PM ET.

PIII Forecast - Frequently Asked Questions

What is P3 Health Partners' forecast for 2024?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for P3 Health Partners is $4.75, with a high forecast of $5.00 and a low forecast of $4.50.

Should I buy or sell P3 Health Partners stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last year. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PIII shares.

Does P3 Health Partners's stock price have much upside?

According to analysts, P3 Health Partners's stock has a predicted upside of 264.64% based on their 12-month stock forecasts.

Do Wall Street analysts like P3 Health Partners more than its competitors?

Analysts like P3 Health Partners less than other "medical" companies. The consensus rating score for P3 Health Partners is 2.67 while the average consensus rating score for "medical" companies is 2.72. Learn more on how PIII compares to other companies.

This page (NASDAQ:PIII) was last updated on 7/21/2024 by Staff

From Our Partners